These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15837601)

  • 21. A silver bullet for the treatment of depression?
    Duman RS
    Neuron; 2007 Sep; 55(5):679-81. PubMed ID: 17785173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant drug action--From rapid changes on network function to network rewiring.
    Rantamäki T; Yalcin I
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():285-92. PubMed ID: 26066070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limitations to enhancing the speed of onset of antidepressants - are rapid action antidepressants possible?
    Artigas F
    Hum Psychopharmacol; 2001 Jan; 16(1):29-36. PubMed ID: 12404595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
    Blier P; de Montigny C
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):91S-98S. PubMed ID: 10432494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new concept of antidepressant drugs action: clinical and preclinical data].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidating the antidepressant actions of substance P (NK1 receptor) antagonists.
    Rupniak NM
    Curr Opin Investig Drugs; 2002 Feb; 3(2):257-61. PubMed ID: 12020057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance.
    Richelson E
    J Clin Psychiatry; 2003; 64 Suppl 13():5-12. PubMed ID: 14552650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
    Tsai SJ
    Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of CREB in depression and antidepressant treatment.
    Blendy JA
    Biol Psychiatry; 2006 Jun; 59(12):1144-50. PubMed ID: 16457782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can monoamine-based therapies be improved?
    Demitrack MA
    J Clin Psychiatry; 2002; 63 Suppl 2():14-8. PubMed ID: 15453009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
    O'Donnell JM; Marek GJ; Seiden LS
    Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptides: relevance in treatment of depression and anxiety disorders.
    Madaan V; Wilson DR
    Drug News Perspect; 2009; 22(6):319-24. PubMed ID: 19771321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.
    Conti B; Maier R; Barr AM; Morale MC; Lu X; Sanna PP; Bilbe G; Hoyer D; Bartfai T
    Mol Psychiatry; 2007 Feb; 12(2):167-89. PubMed ID: 17033635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of various antidepressants on heart rate and electrodermal activity during psychophysiological examinations of depressive patients.
    Barg T; Wolfersdorf M; Ruppe A
    Pharmacopsychiatry; 1996 Nov; 29(6):216-9. PubMed ID: 8956351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities.
    Baghai TC; Volz HP; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):198-222. PubMed ID: 17071541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antidepressants and cytokines--clinical and experimental studies].
    Obuchowicz E; Marcinowska A; Herman ZS
    Psychiatr Pol; 2005; 39(5):921-36. PubMed ID: 16358592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?
    Nielsen DM
    Life Sci; 2006 Jan; 78(9):909-19. PubMed ID: 16122764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interrelations between neuromediators implicated in depression and antidepressive drugs].
    Tassin JP
    Encephale; 1994 Dec; 20 Spec No 4():623-8. PubMed ID: 7895628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ["How quickly do antidepressants works"?].
    Regen F; Anghelescu I
    MMW Fortschr Med; 2006 May; Spec no. 2():82-6. PubMed ID: 20104720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.